Myocardial Infarction
Conditions
Keywords
aldosterone, myocardial infarction, cardiac remodeling
Brief summary
This study aims to determine whether aldosterone blood levels are predictive of cardiac remodeling at 6 months following myocardial infarction with ST elevation (STEMI), independently of conventional predictive factors (size of myocardial infarction, age, hypertension, etc.) in revascularized patients during the acute phase of MI.
Detailed description
After myocardial infarction, the evolution toward cardiac failure is generally linked to a progressive worsening of cardiac dysfunction and remodeling. Cardiac remodeling is largely the consequence of myocardial injury due to myocardial infarction, although other parameters including age, arterial hypertension, etc. may also represent important predictors. Aldosterone blood levels measured within the first hours of admission for myocardial infarction is associated with increased rates of adverse outcomes. Aldosterone acts on wound healing and fibrosis processes in the myocardium as well as on systemic volemia.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Man or woman hospitalized for a first myocardial infarction with known shift of the segment ST revascularized in acute phase by primary angioplasty and dated less than 4 days * Patient presenting a stable clinical state * Patient presenting a regular sinusal cardiac rhythm * Patient having an age ≥ 18 years
Exclusion criteria
* Counter-indication with examination MRI * Severe claustrophobia * Antecedent of over-sensitiveness to gadolinium salts * Nonischaemic Cardiopathy * Cardiac surgery planed in the 6 months * Women into old to procreate without effective contraception
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiac remodeling within 6 months of myocardial infarction as defined as the change in left ventricle volumes (increase of more than 20 % of the diastolic volume of the left ventricle) | from initial assessment to 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Vascular and cardiac parameters measured during the initial assesment and at 6 months (both functional and structural - by echocardiography or MRI) | from initial assessment to 6 months |
| Long-term cardiac remodeling measured by echocardiography at 3 to 9 years of initial enrollment | at 3 to 9 years of initial enrollment |
Countries
France